v3 Template
C

CROSSJECT

Pharmaceuticals / Healthcare ~280 employees
Founded
--
Employees (Est.)
~280
14 leaders known
Total Funding
$34.3M
Funding Rounds
4
Last Funding
2025-06-24

About CROSSJECT

CROSSJECT is a specialty pharmaceutical company focused on revolutionizing the delivery of rapid-acting emergency medications through its innovative needle-free auto-injector, ZENEO(r), designed for life-threatening emergency situations.

Products & Services

ZENEO(r):A needle-free, pre-filled, single-use auto-injector that is fast, reliable, safe, and easy to use, designed for emergency situations such as epileptic seizures, acute adrenal crises, and allergic shocks.
Pipeline Products:Includes treatments for acute adrenal insufficiency, epileptic seizures, allergic shock (anaphylaxis), and other undisclosed products under development.

Specialties

Needle-free injection technology Emergency medication delivery Auto-injector innovation

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Capital Increase
T: -
FT: Capital Increase
A: 6183519
MR: -
FA: €5.7 million
FAN: 6183519
D: 2025-06-24
FD: 2025-06-24
3 investors
2 RT: Grant and Subsidized Loan
T: -
FT: Grant and Subsidized Loan
A: 7452000
MR: -
FA: 6.9 million euros
FAN: 7452000
D: 2024-07-10
FD: 2024-07-10
2 investors
3 RT: Rights Offering
T: -
FT: Rights Offering
A: 8640000
MR: -
FA: €8 million
FAN: 8640000
D: 2024-04-30
FD: 2024-04-30
1 investors
4 RT: Convertible Debt
T: -
FT: Convertible Debt
A: 12000000
MR: -
FA: up to €12 million
FAN: 12000000
D: 2024-02-27
FD: 2024-02-27
1 investors
Capital Increase Latest
2025-06-24
$6.2M
3 investors (Pro only)
Grant and Subsidized Loan 2024-07-10
$7.5M
Rights Offering 2024-04-30
$8.6M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

X

Xavière CASTANO

Co-Founder and CSR Director

P

Patrick ALEXANDRE

Founder and CEO

LinkedIn (Pro only)
C

Charley MICHAUX

Procurement Director

I

Isabelle LIEBSCHUTZ

Director of Quality and Regulatory Affairs Member of the Executive Board

D

Didier MORIN

Industrial Director

M

Marianne SVENSSON

Administrative and Financial Director

View 11 more team members with Pro

Unlock Full Team Directory

Recent News

CROSSJECT Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Pharmaceuticals / Healthcare
Company Size
~280 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro